Navigation Links
Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
Date:7/9/2008

s uveitis.

About Noninfectious Uveitis

Uveitis is an inflammation of the internal structures of the eye. Uveitis can be described by the underlying condition that causes it: autoimmune (noninfectious), bacterial, viral, parasitic and eye trauma, and by the part of the eye that it affects: anterior, intermediate, posterior and panuveitis. Noninfectious uveitis affects approximately two hundred forty thousand people worldwide and can lead to complications, such as glaucoma, cataract and total vision loss. Current treatments include topical and oral corticosteroids, steroidal implants and immunosuppressive drugs; however, these generally have limited success and can lead to adverse events.

About Cerimon Pharmaceuticals

Cerimon Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to developing and commercializing therapeutic products for autoimmune diseases, inflammation and pain. Cerimon believes these new treatment options will enable physicians to further improve the lives of their patients.

Cerimon currently has two drugs in clinical development. The Company's autoimmune program has two development programs. The lead program is a Phase IIb study in which Simulect(R) (basiliximab) is being assessed as a treatment for moderate-to-severe, steroid-refractory ulcerative colitis (UC). The second program is studying Simulect as a treatment for noninfectious uveitis in a Phase II study. Cerimon's lead asset in its pain portfolio is the Company's topical formulations of diclofenac. The Company is in mid-stage clinical testing with its topical diclofenac products.

The Company continues to seek additional assets to add to its development pipeline and is financed by the premier investors MPM, Nomura Phase4 Ventures and OrbiMed Advisors.

For more information on Cerimon, please visit the Company's website at http://www.cerimon.com .


'/>"/>
SOURCE Cerimon Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
2. Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch
3. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
4. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
7. Isis Pharmaceuticals Conference Call Notice
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
10. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
11. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... DUBLIN, Ohio , Aug. 29, 2014  In ... addresses how to leverage a hospital pharmacy as a ... president and national practice leader for Cardinal Health,s Innovation ... quality pharmacy care can benefit both hospitals and patients. ... orders is only one part of their job in ...
(Date:8/29/2014)... DUBLIN , August 29, 2014 ... management and collaboration software has announced a major new ... services, founded by renowned pathology expert, Dr. Marius ... advance of the 26th European Congress of Pathology which ... in the ExCeL Arena, London ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com announces that ... its catalogue: North America Aesthetic Lasers ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html North ... to 2020 Summary GlobalData,s new report, ... Outlook to 2020", provides key market data on ...
Breaking Medicine Technology:Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16
... May 20, 2011 Advanced Life Sciences ... it has cancelled its Annual Meeting of Shareholders, which ... 24, 2011.   (Logo:   http://photos.prnewswire.com/prnh/20080218/ALSLOGO ) ... Advanced Life Sciences is a biopharmaceutical company engaged ...
... The U.S. Food and Drug Administration today approved Sutent ... located in the pancreas that cannot be removed by ... the body (metastatic). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... are slow-growing and rare. It is estimated that there ...
Cached Medicine Technology:FDA Approves Sutent for Rare Type of Pancreatic Cancer 2
(Date:8/30/2014)... Recently, Top 10 Best SEO ... and announced that BlueHost and JustHost ( http://www.justhost.com/track/seohosts ... want to buy high quality web hosting. ... best web host companies who outperform their competitors ... top-level support.” A spokesman for Top 10 Best ...
(Date:8/30/2014)... 31, 2014 Recently, iFitDress.com, one of ... new designs of classy bridesmaid dresses . For ... (from 22 percent off to 62 percent off) for ... beautiful items. , True enough, iFitDress.com is an ... occasion gowns. The company persists in making trendy products ...
(Date:8/30/2014)... Fast hosting is a great choice ... compared many professional web hosting suppliers and announces ... are the suppliers of fastest web hosting in ... good fast hosting supplier. Actually, these companies have ... speed and customer support. People can get the ...
(Date:8/30/2014)... 2014 Recently, Skmen.com, a well-known clothing ... casual dresses . Before the middle of September, all ... discounted price, from 15 to 30 percent off. ... long casual outfits are carefully made and come with ... for the wearers. Skmen.com is popular for its fashionable, ...
(Date:8/30/2014)... TX (PRWEB) August 30, 2014 Information ... Pros company to introduce better prices to consumers in ... plans can be found when using the open system ... national lookup system available to use this year can ... insurance based on general location and not from medical ...
Breaking Medicine News(10 mins):Health News:Great Web Hosting Suppliers Recently Recommended by Top10BestSEOHosting.com 2Health News:Classy Bridesmaid Dresses Announced By Loved Online Supplier iFitDress.com 2Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:Huge Deals On 2014 Long Casual Dresses Unveiled By Skmen.com 2Health News:Term Life Insurance Rates Now Found Nationally by New Insurer Finder Tool 2
... conducting an internal survey to better help diplomats cope with ... , a Department official said in testimony to Congress on ... State Department's Office of Medical Services, told a House of ... the Department's intranet system on June 1, and will collect ...
... female relatives may be unaware they carry a genetic risk ... casts doubt on current genetic testing guidelines . ... gene mutation in women with fewer than two female relatives ... sides of the family, according to researchers in California. ...
... Climate models represent variability in ocean heat content ... previously believed , a study by an Indian ... previously at Livermore's Program for Climate Model Diagnosis ... used 13 numerical climate models to find the ...
... upper echelons of the human brain's chain-of-command, has found ... in charge of the brain . ,Neuroscientists ... found that these two commanders are networks of brain ... work toward a common intention i.e. control of voluntary, ...
... die each year in the Asia-Pacific region due to ... regional conference on Wednesday . ,There ... Southeastern Asia whose deaths are attributed to something as ... UN children's agency (UNICEF) regional advisor Stephen Atwood. ...
... guesthouse inside the campus to save a dozen chinar trees ... Chancellor Abdul Wahid Qureshi halted the construction inside the chinar ... had launched an aggressive campaign to draw public attention to ... for the construction. ,"I have passed orders so ...
Cached Medicine News:Health News:US Concerned About Mental Health of Diplomats in Iraq, Afghanistan 2Health News:IIT Delhi Scientist Finds Climate Models Consistent With Ocean Warming Observations 2Health News:Two, Not One Networks Rule Brain's Voluntary Chain-of-command 2Health News:Two, Not One Networks Rule Brain's Voluntary Chain-of-command 3Health News:Decline in Breastfeeding Linked to Child Deaths in Asia: UNICEF 2
... CytoFuge 2 is the perfect solution for ... controls and new snap-seal Filter Concentrators make ... processed quickly, silently and conveniently on any ... are consistent: easy to scan monolayer cell ...
Unique "finger-stick" collection system utilizes a capillary tube for easy blood drawing; no "scooping" necessary. After draining into a microtube, blood is centrifuged and serum or plasma is easily ...
... Productivity, improved safety and lower cost per test ... to sample prep bottlenecks in the busy clinical ... compact and quiet centrifuge spins standard 5 mL ... it produces quality serum or plasma equal to ...
Used to provide drainage of urine from the bladder. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Inte...
Medicine Products: